ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,721.60
-1.06%
S&P ASX All Technology
3,063.30
-0.61%
Brent Oil
84.08
0.62%
US Dollar vs AUD
1.52046
0.00%
Bitcoin
61,009.36
-0.29%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Intellia Therapeutics Inc (NTLA)

  7. Intellia Therapeutics Inc (NTLA) News

NTLA Intellia Therapeutics Inc

23.10
0.10 (0.43%)
Pre Market
Last Updated: 20:26:19
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Intellia Therapeutics Inc NTLA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.10 0.43% 23.10 20:26:19
Open Price Low Price High Price Close Price Previous Close
23.00
more quote information »

Recent News

Date Time Source Heading
02/5/202421:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
29/4/202421:30GLOBEIntellia Therapeutics to Present Updated Data from Phase 1/2..
18/3/202422:30GLOBEIntellia Therapeutics Announces First Patient Dosed in the..
06/3/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/2/202409:17EDGAR2Form 8-K - Current report
23/2/202408:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/2/202408:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202423:45EDGAR2Form 8-K - Current report
22/2/202423:30GLOBEIntellia Therapeutics Announces Fourth Quarter and Full-Year..
15/2/202423:30BWIntellia Therapeutics and ReCode Therapeutics Announce..
14/2/202423:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
02/2/202408:05EDGAR2Form 8-K - Current report
01/2/202409:00GLOBEIntellia Therapeutics Announces Publication of Positive..
30/1/202408:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:05EDGAR2Form 144 - Report of proposed sale of securities
06/1/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:07EDGAR2Form 8-K - Current report
05/1/202408:01GLOBEIntellia Therapeutics Highlights its Three-Year Strategic..
04/1/202409:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202323:00EDGAR2Form 8-K - Current report
25/11/202301:30EDGAR2Form S-3ASR - Automatic shelf registration statement of..
14/11/202323:30GLOBEIntellia Therapeutics Receives European Union Orphan Drug..
10/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:45EDGAR2Form 8-K - Current report
09/11/202323:30GLOBEIntellia Therapeutics Announces Third Quarter 2023 Financial..
03/11/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202322:11EDGAR2Form 8-K - Current report
02/11/202322:00GLOBEIntellia Presents New Interim Data from the Ongoing Phase 1..
26/10/202322:30GLOBEIntellia Therapeutics to Present Updated Data from Ongoing..
18/10/202322:30EDGAR2Form 8-K - Current report
18/10/202322:00GLOBEIntellia Therapeutics Announces FDA Clearance of..
13/10/202323:38GLOBEIntellia Therapeutics Receives Priority Medicines (PRIME)..
03/10/202322:19EDGAR2Form 8-K - Current report
03/10/202322:00GLOBERegeneron and Intellia Announce Expanded Research..
04/8/202306:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202321:45EDGAR2Form 8-K - Current report
03/8/202321:30GLOBEIntellia Therapeutics Announces Second Quarter 2023..
03/8/202307:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202306:45EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

NASDAQ
NTLA
Intellia Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved